Ability Biologics is a pioneer in the application of generative Artificial Intelligence (AI) to therapeutic discovery, focusing on discovering and developing potent and selective antibody therapeutics for cancer and immune-related disorders
Ability Biologics is a pioneer in the application of generative Artificial Intelligence (AI) to therapeutic discovery, focusing on discovering and developing potent and selective antibody therapeutics for cancer and immune-related disorders.
The top three firms on F4's Biotech & Life Sciences investor list.